Par Drugs and Chemicals Limited Profit Margin

The latest profit margin for PAR.NS is 13.31% as of June 2026. That compares with 13.55% in the prior-year period — down 1.8% year over year. That is above the sector sector average of 13.2%. Investors often review this figure alongside Par Drugs and Chemicals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, PAR.NS's profit margin moved from 13.55% to 13.31% — a 1.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Par Drugs and Chemicals Limited's valuation or profitability profile.

Against its sector companies, PAR.NS currently prints 13.31% for profit margin, while the sector average sits near 13.2%. That is roughly 0.8% above the sector mean. Large gaps often invite a closer look at Par Drugs and Chemicals Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Par Drugs and Chemicals Limited converts resources into returns. At 13.31%, PAR.NS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 13.55% in the prior-year period — down 1.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PAR.NS's profit margin (13.31%), review year-over-year change from 13.55%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.